Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-04-03

Clinical Trial Update: The Effect of Pramlintide on Meal Time Insulin Bolus [NA]

View source ↗

Summary

Clinical trial evaluating whether pramlintide affects the meal-time insulin bolus in people with Type 1 diabetes. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • pramlintide (pramlintide)

Snippet

Sponsor: Diabetes Care Center | Conditions: Type 1 Diabetes | NA | Status: COMPLETED